secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-08-27T12:30:31+00:00
Accession:  0001640334-26-001421
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences announces 1-for-9 reverse stock split effective Aug 28, 2026
-------------------------------------------------------------------------------

- Reverse split ratio 1-for-9, effective 5:00 p.m. ET Aug 28, 2026; split-adjusted trading begins Aug 31, 2026.
- Outstanding shares reduced from 4,929,966 to ~547,774; authorized shares cut from 500M to 55,555,556.
- New CUSIP 04301G805; no fractional shares, each fractional share rounds up to one whole share.
- Warrants and derivatives adjust per terms; shareholder pro-rata ownership unchanged.
- Purpose: improve marketability and liquidity of common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426001421/0001640334-26-001421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426001421/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-001421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer